Ranked above it

Care Bare Rx
Tells you exactly what you're buying — but $199 is a starting point, not a rate.
#1 on our NAD+ provider ranking, above Ivim Health at #52.
Read the Care Bare Rx review →
Provider review
A $74.99/mo membership the headline omits — and a quiz price that contradicts it.
The $133/mo compounded-tirzepatide headline omits a separately required $74.99/mo membership (disclosed only in small print on that same page). Independently, Ivim's own live qualification-quiz configuration discloses "Compounded GLP-1 Options starting at $249/month," payable upfront, for what its site calls the same product category — a contradiction Ivim has with itself, not a promo-versus-standing-rate gap that resolves on a closer read.
Reviewed by Marcus Webb
Transparency scorecard
1 of 4 disclosed openly
What Ivim Health discloses about itself, read from its own pages — not estimated.
Pharmacy named & regulated
Not disclosed
Does not name a pharmacy or state a regulatory category anywhere on its own site.
State coverage published
Not disclosed
Publishes no state coverage list — availability is something you learn during signup.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Not disclosed
The advertised price requires a prepay, auto-refill, or other commitment we found and named.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
Ranked above it

Care Bare Rx
Tells you exactly what you're buying — but $199 is a starting point, not a rate.
#1 on our NAD+ provider ranking, above Ivim Health at #52.
Read the Care Bare Rx review →What this price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not confirmed
The catch — Two stacked mechanisms, both sourced to Ivim's own pages: (1) a $74.99/mo membership required before any medication ships, not mentioned in the $133/mo tirzepatide headline itself; (2) medication is sold in prepaid multi-month "Program" terms (Ivim's own Terms and Conditions, §§16 and 29, name "four- or six-month programs"), and its own live qualification quiz discloses a $249/month price for the same product category that "must be paid upfront" — a different billing structure than the recurring-sounding $133/mo headline.
See plans at Ivim HealthPrices read from Ivim Health's own site · August 2026
What they advertise
Compounded tirzepatide: Ivim's own compounded tirzepatide page headlines "Starting at $133/mo," with a footnote elsewhere on the same page stating, "Medical programs require an Ivím membership at $74.99/month." Compounded semaglutide: its own compounded semaglutide page headlines "Starting at $149/mo," with the identical $74.99/month membership requirement disclosed on that same page. Sermorelin: its own sermorelin page headlines "$129 + $75/mo Membership" directly beside the price — a more transparent disclosure than either GLP-1 page's small-print footnote.
What you actually pay
By the marketing pages' own math: tirzepatide $133 + $74.99 membership = $207.99 combined; semaglutide $149 + $74.99 membership = $223.99 combined; sermorelin $129 + $75 membership = $204 combined. But Ivim's own live qualification-quiz configuration (fetched directly from ivimhealth.com/wp-content/reactpress/apps/forms/public/json/flows/weightloss-quiz.json, step 18) states instead: "Ivím's low cost out-of-pocket Compounded GLP-1 Options starting at $249 / month," with the disclosure "Pricing is per month and must be paid upfront. $74.99/mo membership is also required." That is a materially higher, differently-billed figure ($249 prepaid + $74.99/mo = $323.99 combined) for what Ivim's own site calls the same product category — covering both tirzepatide and semaglutide alike, since the quiz disclosure doesn't distinguish between them — a contradiction Ivim has with itself, and one it does not settle anywhere short of an actual medical intake.
Money you will meet later
Ivim Services LLC dba Ivim (a real company, BBB-accredited since 2/28/2023, A+ rating, business start date 4/29/2022, with two named founders and a named Chief Medical Officer on its own About page) is a live, operating telehealth company selling compounded tirzepatide, a sublingual sermorelin product, compounded liraglutide, branded GLP-1 referrals, and a long tail of supplements. Nothing here rises to what got MEDVi excluded from this site outright — documented deepfaked patient photos and fabricated physician personas. No independent journalism names Ivim. The single "lawsuit" page that surfaces in search (lawfold.com) is a template mass-tort marketing page with no docket, no court and no named plaintiff, which is advertising rather than litigation; the one genuine court record is Ivim's own amicus brief supporting the compounding industry against FDA restrictions. What does remain is three things: an FDA warning letter (MARCS-CMS 721816, February 20, 2026) over a mislabeled-compounder claim, a contradiction across Ivim's own legal documents about which state has jurisdiction over it, and a pricing structure that doesn't match its own $133/mo headline — a mandatory $74.99/mo membership stacked underneath it, medication sold in prepaid multi-month "Program" terms with an early-cancellation restocking fee, and a live quiz disclosure of $249/month (paid upfront) for the same product category the marketing page prices at $133/mo.
Ivim Health appears on our sermorelin provider ranking, our tirzepatide provider ranking, our semaglutide provider ranking, our NAD+ provider ranking and our combined weight loss injections ranking. Nothing on this page is a performance claim.
Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.
Ivim Health does not name the pharmacy that fills your prescription.
Unknown category. Ivim's own compounded tirzepatide page states only, "Ivím only selects FDA-inspected, state-regulated compounding pharmacies that meet regulatory board standards for quality and safety" — neither "503A" nor "503B" appears anywhere checked (product pages, Terms and Conditions, Refund and Returns Policy, Membership Agreement, Privacy Policy, or HIPAA Notice), and no specific pharmacy is named by name anywhere.
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
Not published. No state list and no "all 50 states" claim appears anywhere on the site's public pages (product pages, Terms and Conditions, Membership Agreement, Refund and Returns Policy, Privacy Policy, or HIPAA Notice) — a reader only reaches a location field after completing Ivim's full medical questionnaire.
The part they would rather you skipped
FDA issued Ivim a warning letter (MARCS-CMS 721816, February 20, 2026, Center for Drug Evaluation and Research), addressed to Ivim Services LLC dba Ivim at 4200 Regent Street, Suite 200, Columbus, OH 43219 — the identical address confirmed as Ivim's own BBB profile address (A+ rating, accredited since 2/28/2023). The letter states FDA reviewed ivimhealth.com in December 2025 and found the compounded semaglutide and tirzepatide products displayed on the site identify "Ivim" on the pictured label, "suggesting Ivim is the compounder of those drugs when in fact it is not" — misbranded under FDCA §§502(a) and 502(bb), the same single-issue template as the first of BluefitMD's two citations on this same roster, and the same disclosable-not-disqualifying shape as Strut Health's letter. Independent of the FDA letter, Ivim's own legal documents contradict each other about which state even has jurisdiction over the company: its Terms and Conditions states it is "registered in Michigan... registered office at 336 W 1st St Ste 113, Flint, MI 48502" and that the Terms are "governed by... the laws of the State of Michigan" (§18) — then, in the same document, states disputes are subject to "exclusive jurisdiction and venue in the state and federal courts located in Franklin County, Ohio" (Columbus, where the FDA letter and BBB profile both place it) and that arbitration "will be conducted in Franklin County, Ohio." Its separate Membership Agreement states Michigan law AND Michigan jurisdiction, but directs legal notices to "Ivim's Principal Mailing Address at 4200 Regent Street, Suite 200, Columbus, OH 43219" — the Ohio address. Three of Ivim's own documents name three different combinations of state and address for what is legally the same company.
None of this is unique to Ivim Health — the whole category shares it.
The providers we rank on our NAD+ provider ranking — the most specific board Ivim Health sits on — in the order that board ranks them. It sells into other categories too; see the boards listed above under the bottom line.




45 more providers rank on our NAD+ provider ranking — see the full ranking. Every provider we review →
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Ready to get started?
Prices and plans in this category change often — check Ivim Health's current pricing before you decide. Ours was read from their own site in August 2026.
Facts on this page reflect Ivim Health's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Ivim Health's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.
Ivim Health
4 compounds from $129/mo + $75/mo membership